HAMP and metabolic disease: Furthermore, the involvement and impact of ascorbate and the ascorbate–iron complex with regards to the new emerging therapies and strategies for iron metabolic disorders that have been proposed based on hepcidin agonists, antagonists and modified structural products, may help to identify optimal therapies for different categories of patients [221,222,223].